Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

MELDONIUM IMPURITY F CRS (25 MG)

MELDONIUM IMPURITY F CRS (25 MG)

NA

DISCOVER
SULFADIMETHOXINE CRS (60 MG)

SULFADIMETHOXINE CRS (60 MG)

122-11-2

DISCOVER
SODIUM ALENDRONATE FOR SYSTEMSUITABILITY CRS (15 MG)

SODIUM ALENDRONATE FOR SYSTEMSUITABILITY CRS (15 MG)

121268-17-5

DISCOVER
SULFADIMETHOXINE FOR PEAK IDENTIFICATION CRS (10 MG)

SULFADIMETHOXINE FOR PEAK IDENTIFICATION CRS (10 MG)

122-11-2

DISCOVER
CLINDAMYCIN PHOSPHATE FOR SYSTEM SUITABILITY CRS (3.073 MG)

CLINDAMYCIN PHOSPHATE FOR SYSTEM SUITABILITY CRS (3.073 MG)

24729-96-2

DISCOVER
PRILOCAINE FOR PEAK IDENTIFICATION CRS (20 MG)

PRILOCAINE FOR PEAK IDENTIFICATION CRS (20 MG)

1786-81-8

DISCOVER
GEMCITABINE IMPURITY C CRS (25 MG)

GEMCITABINE IMPURITY C CRS (25 MG)

NA

DISCOVER
STAVUDINE  IMPURITY I CRS (5 MG)

STAVUDINE IMPURITY I CRS (5 MG)

122567-97-9

DISCOVER
HIGH-MOLECULAR-MASS MACROGOL CRS (10 MG)

HIGH-MOLECULAR-MASS MACROGOL CRS (10 MG)

25322-68-3

DISCOVER
GLUCOSAMINE SULFATE POTASSIUMCHLORIDE CRS (10 MG)

GLUCOSAMINE SULFATE POTASSIUMCHLORIDE CRS (10 MG)

NA

DISCOVER
ETHIONAMIDE FOR SYSTEM SUITABILITY CRS (10 MG)

ETHIONAMIDE FOR SYSTEM SUITABILITY CRS (10 MG)

536-33-4

DISCOVER
MILK THISTLE DRY EXTRACT HRS (120 MG)

MILK THISTLE DRY EXTRACT HRS (120 MG)

22888-70-6

DISCOVER